Chronic coronary syndrome

4 trials 4 recruiting MedDRA PT
4 Registered trials
4 Recruiting
4 Unique sponsors
4 Unique IMPs
0 Commercial trials
Drug classes (ATC)
— ATC code not specified 3
B Haematology (ATC B) 1
Mechanism of action (INN-stem analysis)
Unknown / small molecule 4 substances
Phase III: 2 Phase IV: 2

Filter these 4 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 4 trials

Phase III

2 trials
  • Dolnoslaskie Centrum Chorob Serca Im. Prof. Zbigniewa Religi Medinet Sp. z o.o. Academic
    IMP not specified
    2025-521892-30-00 1 country 2025 n=1,703
    Recruiting
  • Insel Gruppe AG Academic
    IMP not specified
    2023-509717-36-00 7 countries 2024 n=1,700
    Recruiting

Phase IV

2 trials
  • Centre Hospitalier Universitaire De Caen Normandie Academic
    CLOPIDOGREL; D,L-LYSINE ACETYLSALICYLATE; PRASUGREL; TICAGRELOR
    2023-507545-28-00 1 country 2026 n=1,700
    Recruiting
  • Fondazione Ricerca e Innovazione Cardiovascolare Academic
    IMP not specified
    2024-519706-13-00 4 countries 2026 n=576
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Dolnoslaskie Centrum Chorob Serca Im. Prof. Zbigniewa Religi Medinet Sp. z o.o. Academic 1 Phase III 1
Insel Gruppe AG Academic 1 Phase III 1
Centre Hospitalier Universitaire De Caen Normandie Academic 1 Phase IV 1
Fondazione Ricerca e Innovazione Cardiovascolare Academic 1 Phase IV 1
New trials by year
2024
1
2025
1
2026
2
← All indication landscapes